Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Suarez-Garcia, I; Ruiz-Alguero, M; Alejos, B; Garcia-Yubero, C; Belza, MJ; Espacio, R; Hernandez, J; Sanchez, JM; Garaialde, A; Socas, MDA; Alcaraz, A; de Galarreta, BPR; Madrid, OJM; Cuellar, IG; Gomez-Ayerbe, C; Olalla, J; Jarrin, I.

Brief Report: Patients' Experiences and Opinions After Desimplification of Their Single-Tablet Regimens for the Treatment of HIV Infection: A Survey in a Multicentre Cohort

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2022; 90(1): 62-68 Nº de citas: 3 [doi:10.1097/QAI.0000000000002923]

Guembe, MG; Pensado, YT; Picado, FT; Diez, C; Latorre, LP; Fanciulli, C; Vazquez, FP; de Quiros, JCLB; Berenguer, J; Ortega, BP; Machado, M; Minero, MV; Garcia, PM; Santiago, EB; Galar, A; Catalan, P; Alonso, R; Bellon, JM; Lois, TAE; Gregorio Maranon Microbiology-ID.

SARS-COV-2 Infection in People Living with HIV: Experience from a Tertiary Hospital in Madrid

AIDS RESEARCH AND HUMAN RETROVIRUSES. 2022; 38(5): 394-398 Nº de citas: 4 [doi:10.1089/aid.2021.0159]

Serrano-Villar, S; Lopez-Huertas, MR; Jimenez, D; Galera, C; Martinez-Sanz, J; Moreno, E; Muriel, A; Gutierez, F; Busca, C; Portilla, J; Bisbal, O; Iribarren, JA; Tejerina, F; de los Santos, I; Moreno, S.

Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens

Frontiers in Immunology. 2022; 13: Nº de citas: 9 [doi:10.3389/fimmu.2022.848630]

Tejerina, F; Catalan, P; Rodriguez-Grande, C; Adan, J; Rodriguez-Gonzalez, C; Munoz, P; Aldamiz, T; Diez, C; Perez, L; Fanciulli, C; de Viedma, DG; Gregorio Maranon Microbiol ID COVI.

Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19

BMC INFECTIOUS DISEASES. 2022; 22(1): Nº de citas: 82 [doi:10.1186/s12879-022-07153-4]

Virseda-Berdices, A; Rojo, D; Martinez, I; Berenguer, J; Gonzalez-Garcia, J; Brochado-Kith, O; Fernandez-Rodriguez, A; Diez, C; Hontanon, V; Perez-Latorre, L; Mican, R; Barbas, C; Resino, S; Jimenez-Sousa, MA.

Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients

BIOMEDICINE & PHARMACOTHERAPY. 2022; 147: Nº de citas: 9 [doi:10.1016/j.biopha.2022.112623]

Lazarus JV; Villota-Rivas M; Fernández I; Gea F; Ryan P; López SA; Guy D; Calleja JL; García-Samaniego J.

A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid.

Communications Medicine. 2022; 2(1): 20-20 Nº de citas: 5 [doi:10.1038/s43856-022-00077-9]

Virseda-Berdices, A; Brochado-Kith, O; Diez, C; Hontanon, V; Berenguer, J; Gonzalez-Garcia, J; Rojo, D; Fernandez-Rodriguez, A; Ibanez-Samaniego, L; Llop-Herrera, E; Olveira, A; Perez-Latorre, L; Barbas, C; Rava, M; Resino, S; Jimenez-Sousa, MA.

Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(3): 719-726 Nº de citas: 7 [doi:10.1093/jac/dkab444]

Salto-Alejandre, S; Palacios-Baena, ZR; Arribas, JR; Berenguer, J; Carratala, J; Jarrin, I; Ryan, P; De Miguel-Montero, M; Rodriguez-Bano, J; Pachon, J.

( )Impact of early interferon-beta treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort

BIOMEDICINE & PHARMACOTHERAPY. 2022; 146: 112572-112572 Nº de citas: 8 [doi:10.1016/j.biopha.2021.112572]

Conway, B; Rodriguez-Tajes, S; Garcia-Retortillo, M; Perez-Hernandez, P; Teti, E; Ryan, P; Fraser, C; Macedo, G; Amado, LEM; de Ledinghen, V; Fenech, M; Martins, A; Guerra-Veloz, MF; Ntalla, I; Ramroth, H; Vanstraelen, K; Hernandez, C; Mertens, M; O'Loan, J.

Real-world evidence of sofosbuvir/velpatasvir as an effective and simple hepatitis C virus treatment and elimination tool in homeless populations

FUTURE VIROLOGY. 2022; 17(2): 77-86 Nº de citas: 3 [doi:10.2217/fvl-2021-0266]

Valencia, J; Lazarus, JV; Ceballos, FC; Troya, J; Cuevas, G; Resino, S; Torres-Macho, J; Ryan, P.

Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care

LIVER INTERNATIONAL. 2022; 42(2): 309-319 Nº de citas: 7 [doi:10.1111/liv.15095]

Gottlieb, RL; Vaca, CE; Paredes, R; Mera, J; Webb, BJ; Perez, G; Oguchi, G; Ryan, P; Nielsen, BU; Brown, M; Hidalgo, A; Sachdeva, Y; Mittal, S; Osiyemi, O; Skarbinski, J; Juneja, K; Hyland, RH; Osinusi, A; Chen, S; Camus, G; Abdelghany, M; Davies, S; Behenna-Renton, N; Duff, F; Marty, FM; Katz, MJ; Ginde, AA; Brown, SM; Schiffer, JT; Hill, JA; GS-US-540-9012 PINETREE Investigat.

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

NEW ENGLAND JOURNAL OF MEDICINE. 2022; 386(4): 305-315 Nº de citas: 945 [doi:10.1056/NEJMoa2116846]

Branas, F; Galindo, MJ; Torralba, M; Antela, A; Vergas, J; Ramirez, M; Ryan, P; Dronda, F; Busca, C; Machuca, I; Bustinduy, MJ; Cabello, A; Sanchez-Conde, M.

Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817)

PLoS One. 2022; 17(3): Nº de citas: 10 [doi:10.1371/journal.pone.0266191]

Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J.

Diplejía facial aislada como variante atípica del síndrome de Guillain-Barré tras sospecha de infección por SARS-CoV-2.

Revista de la Facultad de Ciencias Medicas de Cordoba. 2021; 78(4): 405-407 Nº de citas: 2 [doi:10.31053/1853.0605.v78.n4.32392]

Thalhammer J; Kindle G; Nieters A; Rusch S; Seppänen MRJ; Fischer A; Grimbacher B; Edgar D; Buckland M; Mahlaoui N; Ehl S.

Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2021; 148(5): [doi:10.1016/j.jaci.2021.04.015]

Berenguer, J; Diez, C; Martin-Vicente, M; Mican, R; Perez-Elias, MJ; Garcia-Fraile, LJ; Vidal, F; Suarez-Garcia, I; Podzamczer, D; Del Romero, J; Pulido, F; Iribarren, JA; Gutierrez, F; Poveda, E; Galera, C; Izquierdo, R; Asensi, V; Portilla, J; Lopez, JC; Arribas, JR; Moreno, S; Gonzalez-Garcia, J; Resino, S; Jarrin, I.

Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort

CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27(11): 1678-1684 Nº de citas: 40 [doi:10.1016/j.cmi.2021.06.023]

Ryan, P; Valencia, J; Cuevas, G; Torres-Macho, J; Troya, J; Pueyo, A; Munoz-Gomez, MJ; Munoz-Rivas, N; Vazquez-Moron, S; Martinez, I; Lazarus, JV; Resino, S.

Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain

INTERNATIONAL JOURNAL OF DRUG POLICY. 2021; 96: 103424-103424 Nº de citas: 9 [doi:10.1016/j.drugpo.2021.103424]

Deutschmann, E; Bucher, HC; Jaeckel, S; Gibbons, S; McAllister, K; Scherrer, AU; Braun, DL; Cavassini, M; Hachfeld, A; Calmy, A; Battegay, M; Cipriani, M; Elzi, L; Young, J; Lopez-Centeno, B; Berenguer, J; Khoo, S; Moffa, G; Marzolini, C; Swiss HIV Cohort Study.

Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors

CLINICAL INFECTIOUS DISEASES. 2021; 73(7): 2145-2152 Nº de citas: 12 [doi:10.1093/cid/ciaa918]

Carrero, A; Berenguer, J; Hontanon, V; Guardiola, JM; Navarro, J; von Wichmann, MA; Tellez, MJ; Quereda, C; Santos, I; Sanz, J; Galindo, MJ; Hernandez-Quero, J; Jimenez-Sousa, MA; Perez-Latorre, L; Bellon, JM; Resino, S; Esteban, H; Martinez, E; Gonzalez-Garcia, J; Grp Estudio Sida GESIDA 36038 Stud.

Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients

CLINICAL INFECTIOUS DISEASES. 2021; 73(7): 2026-2033 Nº de citas: 5 [doi:10.1093/cid/ciaa1396]